Factors associated with pneumococcal vaccination among an urban elderly population in China

Shijun Liu, Yan Liu, Yuyang Xu, Jian Du, Xiaoping Zhang, Xinren Che

2014-10-03articleHuman Vaccines & Immunotherapeutics40 citationsbronze

No readable copy stored yet — this record is metadata only.

Vaccine Coverage and Hesitancy Pneumonia and Respiratory Infections Immune responses and vaccinations

Abstract

OBJECTIVES: To investigate the coverage of the 23-valent pneumococcal polysaccharide vaccine (23-PPV) in the Chinese urban elderly population and to understand the attitudes, knowledge and beliefs of this population toward the 23-PPV vaccination. METHODS: A cross-sectional approach was employed to survey the willingness of this population to receive the 23-PPV vaccination. Two thousand 9 hundred 2 six subjects over the age of 60 y were enrolled via a multi-stage random sampling method from the urban community population in Hangzhou, China. The relationships between the variables and the willingness to receive the 23-PPV vaccination were computed as odds ratios (ORs) by multivariate analysis. RESULTS: Of the participants, 21.77% were willing to undergo 23-PPV vaccination, and 61.65% of the subjects agreed that pneumonia is a serious disease among elderly people. The rate of reasonable perceptions about vaccination, including the perception about vaccine efficacy and safety, among the subjects was below 50%. Only 1.23% of subjects had been vaccinated with 23-PPV, and a similarly low rate was observed for the seasonal influenza vaccine (4.17%). The factors that were independently related to the willingness to receive the 23-PPV vaccine included consensus with the hazards of pneumonia (OR = 1.67, 95% CI: 1.28 - 2.17), the safety of vaccination (OR = 2.00, 95% CI: 1.54 - 2.59), advice about the 23-PPV vaccination from family members (OR = 2.37, 95% CI: 1.39 - 4.40), influenza vaccination history (OR = 2.57, 95% CI: 1.66 - 3.98) and pneumococcal vaccination history (OR = 7.48, 95% CI: 2.4-22.92). CONCLUSION: The administration of the 23-PPV vaccine among the urban elderly population is not optimistic in China. Emphasis on persuasion from families and the improvement of knowledge about vaccination might encourage elderly people to get the 23-PPV vaccination. Suggestions from physicians did not affect the participants' willingness to get the 23-PPV vaccination in multivariate analysis, but elderly people typically visited the Community Health Center (CHC) in their residential districts, and thus, systematic encouragement from healthcare physicians might be the key to increasing 23-PPV vaccination.

Citations in this library

Stored only when both papers are in the corpus — 40 citations exist upstream.

References

2008Barriers to Adult Immunization

1993Immunization of Adults

2013Seasonal Influenza Vaccination Coverage Rate of Target Groups in Selected Cities and Provinces in China by Season (2009/10 to 2011/12)

2001Importance of patients’ perceptions and general practitioners’ recommendations in understanding missed opportunities for immunisations in Swiss adults

2003Barriers and facilitators of pneumococcal vaccination among the elderly

2002Adult pneumococcal vaccination: a review of physician and patient barriers

2007Factors associated with pneumococcal immunisation among hospitalised elderly persons: A survey of patient's perception, attitude, and knowledge

Cited by

2023The coverage and challenges of increasing uptake of non-National Immunization Program vaccines in China: a scoping review

2018Correlation between family physician’s direct advice and pneumococcal vaccination intention and behavior among the elderly in Japan: a cross-sectional study

2020Facilitators and barriers to completing recommended doses of pneumococcal vaccination among community-living individuals aged ≥65 years in Hong Kong – a population-based study

2021Heightened Willingness toward Pneumococcal Vaccination in the Elderly Population in Shenzhen, China: A Cross-Sectional Study during the COVID-19 Pandemic

2019Knowledge, attitude, and practice regarding infection and vaccination in patients with rheumatic diseases in China